Gonadotropin-Releasing Hormone Agonist Suppresses Ovulation, Menses, and Endometriosis in Monkeys: An Individualized, Intermittent Regimen*
article
OA: closed
CC0
⤵ 14 in-corpus citations
AI-generated summary
An individualized, intermittent GnRH agonist regimen suppressed ovulation and menses in 14 of 15 monkeys and resolved endometriosis in 12, while controls showed no change.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This study was designed to test the efficacy of a long-acting GnRH agonist (alpha) for inhibition of ovulation and menses in monkeys as well as suppression of mild to moderate endometriosis through an individualized, intermittent regimen. Endometriosis was surgically induced in 21 cynomolgus monkeys; ectopic tissue viability was verified histologically. GnRH alpha (leuprolide, D-Leu6-Pro9-Net-LHRH, Abbott Laboratories) was injected weekly in treatment cycle 1 (10 microgram/kg, sc; n = 15). Ovulation and menses ceased in 6 of 15 females. For the remaining 9 monkeys, the GnRH alpha dose was increased to 15 microgram/kg weekly in treatment cycle 2. Still, 4 monkeys resisted suppression; in treatment cycle 3, their regimen increased to 15 microgram/kg every fourth day. Thus, anovulation and amenorrhea was achieved in 14 of 15 monkeys within 90 days, seemingly as a result of ovarian desensitization, since GnRH alpha injections usually enhanced serum LH and FSH levels (P less than 0.05). Frequent laparotomies and daily hormonal profiles of estradiol, progesterone, FSH, and LH in serum confirmed these findings. After treatment, 12 of 15 monkeys manifested resolution of ectopic endometrial tissue; concurrently, there was no change in the severity of endometriosis in the 6 saline-injected controls. Six of 15 monkeys became pregnant within 90 days after cessation of GnRH alpha injections; 1 of 6 control females conceived. These findings may encourage consideration of clinical investigations employing individualized and/or intermittent GnRH alpha administration for the treatment of endometriosis or to achieve contraception.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (8)
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Conservative Treatment of Endometriosis via openalex
- Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression via openalex
- Endometriosis: Treatment with hormonal pseudopregnancy and/or operation via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- W2394499451 via openalex
- W1997370287 via openalex
- W9029848 via openalex
Cited by (14)
- Baboon Model for the Study of Endometriosis 2007
- The Baboon as an Appropriate Model for the Study of Multifactoral Aspects of Human Endometriosis 2005
- Endometriosis and Pelvic Pain 1998
- Endometriosis: the present and the future—an overview of treatment options 1992
- Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys 1991
- Basic and clinical aspects of GnRH‐agonists in reproduction 1990
- GnRH Analogues in the Treatment of Endometriosis 1989
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis 1988
- Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis 1988
- Endometriosis 1987
- Treatment of Endometriosis in Monkeys: Effectiveness of Continuous Infusion of a Gonadotropin-Releasing Hormone Agonist Compared to Treatment with a Progestational Steroid* 1986
- Development of an animal model for quantitatively evaluating effects of drugs on endometriosis 1985
- Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin) 1985
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. 1983
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:09:55.985569+00:00
License: CC0
· commercial use OK